Akhter M.P., Turner C.H. (1990): Fluoride intake versus bone strength in rat bones. J. Bone Miner. Res., 5(suppl 1), (98).
Alhava E.M., Olkkonen H., Kauranen P., Kari T. (1980): The effect of drinking water fluoridation on the fluoride content, strength and mineral density of human bone. Acta Orthop. Scand., 51, (413-420).
Badurski J., Sawicki A., Boczoń S. (1994): Osteoporoza. Osteoprint, Białystok.
Baylink D.J., Bernstein D.S. (1967): The effect of fluoride therapy on metabolic bone disease: a histologic study. Clin. Orthop., 55, (51-85).
Baylink D.J., Farley S.M., Smith L. (1983): Characterisation of skeletal response to fluoride in osteoporosis. Clin. Res., 31, (543A).
Boivin G. (1978): Morphometry analysis of fluorotic bone tissue. W: Curvoisier B., Donath A., Baud C.A. Symposium CEMO III: Fluoride and bone. Editions Medecine et Hygiee, Geneva.
Briancon D., Meunier P. (1979): Le traitement de l'osteoporose par l'association fluorure de sodium, calcium, vitamine D. Thesis, Lyon.
Briancon D, Meunier P.J. (1981): Treatment of osteoporosis with fluoride, calcium and vitamin D. Orthop. Clin. North Am., 12, (629-648).
Buckle R.M. (1989): 3-year study of sodium fluoride treatment on vertebral fracture incidence inosteoporosis. J Bone Miner. Res., 4 (suppl 1), (186).
Burkhart J.M., Jowsey J. (1968): Effect of variations in calcium intake on the skeleton of fluoride-fed kittens. J. Lab. Clin. Med., 72, (943- 950).
Cass R.M., Croft J.D., Perkins P., Nye W., Waterhouse C., Terry R. (1966): New bone formation in osteoporosis following treatment with sodium fluoride. Arch. Intern. Med., 118, (111- 116).
Caverzasio J., Imai T., Amman P., Burgener D, Bonjour J.P. (1996): Aluminium potentiates the effect of fluoride on tyrosine phosphorylation and osteoblast replication in vitro and bone mass in vivo. Calcif. Tissue Int., 58, (30-39).
Chavassieux P., Pastoureau P., Boivin G., Chapuy MC., Delmas P.D., Milhaud G., Meunier P.J. (1991): Fluoride-induced bone changes in lambs during and after exposure to sodium fluoride. Osteoporos. Int., 2, (26-33).
Cheng P.T., Bader S.M., Grynpas M.D. (1995): Biphasic sodium fluoride effects on bone and bone mineral. A review. Cells and Materials, 5, (271- 282).
Cremer H.D., Buttner W. (1970): Fluorides in human health. Absorption of fluorides. WHO, Genewa.
Dambacher M.A., Lauffenburger T., Lammble B., Haas H.G. (1978): Long-term effects of sodium fluoride in osteoporosis. W: Courvoisier B., Donath A. Fluoride and bone. Hans Huber, Geneva.
Delmas P.D., Dupuis J., Duboeuf F., Chapuy M.C., Meunier P.J. (1990): Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J. Bone Miner Res., 5 (suppl 1), (143-147).
Ekstrand J., Ehrnebo M., Boreus L.O. (1978): Fluoride bioavailability after intravenous and oral administration: importance of renal clearance and urine flow. Clin. Pharmacol. Ther., 23, (329-337).
Eriksen E.F., Mosekilde L., Meisen F. (1985): Effects of sodium fluoride, calcium phosphate and vitamin D2 on bone balance and remodelling in osteoporotics. Bone, 6, (381-390).
Farley J R., Wergedal J.E., Baylink D.J. (1983): Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone forming cells. Science, 222, (330-332).
Farley S.M., Wergedal J.E., Farley J R., Javier G.N., Schulz EE., Talbot J R., Libanati CR., Lindegren L., Bock M., Goette M.M. (1992): Spinal fractures during fluoride therapy for osteoporosis: relationship to spinal bone density. Osteoporos. Int., 2, (213-218).
Farley S.M.G., Wergedal J.E., Smith L.C., Lundy M.W., Farley J R., Baylink D.J. (1987): Fluoride therapy for osteoporosis: characteristics of the skeletal response by serial measurement of serum alkaline phosphatase activity. Metabolism, 36, (211-218).
Fratzl P., Roschger P., Eschberger J., Abendroth B„ Klaushofer K. (1994): Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle X-ray-scattering study. J. Bone Miner. Res., 9, (1541-1549).
Gambacciani M., Spinetti A., Taponeco F. (1995): Treatment of postmenopausal vertebral osteopenia with monofluorophosphate - a long- term calcium-controlled study. Osteoporos. Int., 5, (467-471).
Glerum J.L. (1987): Fluoride in osteoporosis. Pharmaceutical and clinical aspects with special attention to a slow release preparation. Thesis, University of Utrecht.
Hansson T„ Roos B. (1987): The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3-year) study. Calcif. Tissue Int., 40, (315-317).
Jowsey J., Riggs B.L., Kelly P.J., Hoffman D.L. (1972): Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am. J. Med., 53, (43-49).
Jowsey J., Schenk R.K., Reutter F.W. (1968): Some results of the effect of fluoride on bone tissue in osteoporosis. J. Clin. Endocrinol. Metab., 28, (869-874).
Kanis J.A. (1990): Effect of fluoride on postmenopausal osteoporosis. N. Engl. J. Med., 323, (416-417).
Kanis J A. (1993): Treatment of symptomatic osteoporosis with fluoride. Am. J. Med., 95 (suppl 5A), (53-61).
Kanis J.A., Johnell O , Gullberg G, Allander E., Dilsen G., Gennari C., Lpes-Vaz A.A., Lyritis G.P., Mazzuoli G., Miravet L. (1992): Evidence for the efficacy of bone active drugs in the prevention of hip fracture. Br. Med. J , 305, (1124-1128).
Kanis J.A., Meunier P.J. (1984): Should we use 'fluoride to treat osteoporosis? Q J. Med., 53, (145-164).
Kleerekoper M., Paterson E.L., Nelson D A, Phillips E., Schork M.A., Tilley B.C., Parfitt AM (1991): A randomized trial of sodium fluoride asa treatment for postmenopausal osteoporosis Osteoporos. Int., 1, (155-161).
Lee J.R. (1994): Critical review. Fluoride, 27, (227-228).
Leone N.C., Stevenson C.A., Hilbish T.F, Sosman M.C. (1955): A roentegenologic study of a human population exposed to high-fluoride domestic water: a ten-year study. Am. J Roentgenol. Radium Ther. Nucl. Med., 74, (874- 885).
Lundy M.W., Stauffer M, Wergedal JE., Baylink D.J., Featherstone J.D., Hodgson S.F, Riggs B.L. (1995): Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos. Int., 5, (115- 129).
Mamelle N., Meunier P.J., Dusan R , Guillaume M., Martin J.L., Gaucher A., Prost A., Zeigler G, Netter P. (1988): Risk-benefit ratio of sodium fluoride: treatment in primary vertebral osteoporosis. Lancet, 2, (361-365).
Mamelle N., Meunier P.J., Netter P. (1990): Fluoride and vertebral fractures. (Letter to the editor). Lancet, 336, (243).
Marcelli C., Meunier P.J. (1994): Fluoride therapy: effect on bone microstructure and biomechanics. Presse Med., 23, (1344-1348).
Nagant de Deuxchaisnes C., Devogelaer J.P, Depresseux G, Malghem J., Maldague B. (1990): Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements. J. Bone Miner. Res., 5 (suppl 1), (25-26).
Newesely H. (1972): Mechanisms and action of trace elements in the mineralization of dental hard tissues. Zyma SA, Nyon.
Pak C.Y.C., Sakhaee K, Piziak V., Peterson R.D., Breslau N.A., Boud P., Poindexter J.R, Herzog J., Heardsakhaee A., Haynes S, Adamshuet B., Reisch J.S. (1994): Slow-release sodium fluoride in the treatment of postmenopausal osteoporosis. A randomized controlled trial. Ann. Intern. Med., 120, (625-632).
Parsons V., Mitchell C., Eimond A., Darby A.J. (1983): The use of sodium fluoride and calcium supplements and vitamin D in the treatment of axial osteoporosis. W: Dixon A. St. J., Russell R.G.G., Stamp T.C.B. Osteoporosis - a multidisciplinary problem. Royal Society of Medicine and Academic Press, London.
Rich C., Ensinck J. (1961): Effect of sodium fluoride on calcium metabolism of human beings. Nature, 213, (191-184).
Rigalli A., Ballina J.C., Beinlich A.D., Alloatti R., Puche R.C. (1994): Pharmacokinetic differences between sodium fluoride and sodium monofluorophosphate and comparative bone mass increasing activity of both compounds in the rat. Arzneimittelforschung, 44, (762-766).
Riggs B.L., Hodgson S.F., Hoffman D.L., Kelly P.J., Johnson K.A., Taves D R. (1980): Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence. JAMA 243, (446-449).
the fixture rate in postmenopausal women with osteoporosis. N. Engl. J. Med., 322, (802-809).
Roholm K. (1937): Fluorine intoxication: a clinical hygienic study. H.K.Lewis, London.
Sogaard C.H., Mosekilde L., Richards A. (1994): Marked decrease in trabecular bone quality after five years of sodium fluoride therapy - assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients. Bone, 15, (393- 399).
Teotia S.P.S., Teotia M. (1973): Secondary hyperparathyroidism in patients with endemic skeletal fluorosis. Br. Med. J., 1, (637-640).
Vose G.P., Keele D.K., Milner A.M., Rawley R., Roach T.L., Sprinkle E.E. (1978): Effect of sodium fluoride, inorganic phosphate and oxymetholone therapies in osteoporosis: a six year progress report. J. Gerontol., 33, (204-212).
Wolinsky I., Simkin A., Gugqenheim K. (1972): Effects of fluoride on metabolism and mechanical properties of rat bone. Am. J. Physiol., 223, (46- 50).